Small intestinal bacterial overgrowth recurrence after antibiotic therapy.
about
Small intestinal bacterial overgrowth syndromeUse of rifaximin in gastrointestinal and liver diseasesRifaximin for Irritable Bowel Syndrome: A Meta-Analysis of Randomized Placebo-Controlled TrialsIrritable bowel syndrome: a concise review of current treatment conceptsPharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome.Diagnosis and management of small intestinal bacterial overgrowth.Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance.Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth.Appendectomy as a Risk Factor for Bacteremic Biliary Tract Infection Caused by Antibiotic-Resistant PathogensComparison of the antibacterial activity of essential oils and extracts of medicinal and culinary herbs to investigate potential new treatments for irritable bowel syndrome.Rifaximin pharmacology and clinical implications.Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents.Antibiotics for the treatment of irritable bowel syndromeThe place of antibiotics in management of irritable bowel syndrome: a systematic review and meta-analysisDiagnosis and treatment of small intestinal bacterial overgrowth.An Evidence-based Approach to Therapy in IBS-D: A Case Study Compendium.Recent advances in small bowel diseases: Part I.Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled-data analysis.Small Intestinal Bacterial Overgrowth in Patients with Refractory Functional Gastrointestinal Disorders.Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseasesRifaximin in irritable bowel syndrome: rationale, evidence and clinical useMeta-analysis: antibiotic therapy for small intestinal bacterial overgrowth.Levothyroxine therapy and impaired clearance are the strongest contributors to small intestinal bacterial overgrowth: Results of a retrospective cohort study.Rifaximin therapy of irritable bowel syndrome.Biologic properties and clinical uses of rifaximin.The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson's disease.How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach.Evaluating a bacterial hypothesis in IBS using a modification of Koch's postulates: part 1.Low ileocecal valve pressure is significantly associated with small intestinal bacterial overgrowth (SIBO).Commentary: Towards an effective and safe treatment of small intestine bacterial overgrowth.Bacillus clausii as a treatment of small intestinal bacterial overgrowth.
P2860
Q24262889-F5C96836-CD65-4651-89AD-9E1E17A9D5FBQ26740201-C30FE7A5-7739-4B91-BBC9-67111E9242C0Q26772962-4507CE1E-5356-4751-90C0-ECD9677D9ED2Q26996547-538E6471-3053-439D-836B-E03AE8722D41Q33451900-E71CCB94-8736-421E-A8D5-DD487C53AE12Q33457767-7D1E7DA0-58C6-4147-B495-371A709A65F6Q33459081-C9C85316-88D6-4FCB-9937-4ADAE8C76194Q33648535-12A4F571-C256-4F4A-B43E-13544F0874D5Q33735481-302CB9F5-CD45-4B7C-9E7F-C642EA767707Q34454007-F8BB50E3-4091-48DD-AB6A-8056F5D43D43Q34607677-4DBD3355-62D8-4B08-A1F6-226F04CA64CCQ35018460-0F62BF60-68B8-4CC1-AD8F-0C52AA5E1840Q35691133-BD9821C8-BD6F-4857-8BE3-C6B39FC434CCQ35755340-961BEDDD-ED93-4C1A-A425-6F83729E2C0EQ35860893-CC8B3FA6-C492-4422-9E05-7F4961DB6DECQ35917169-6A82DE5E-1BA1-4427-B669-AB6CF9B5DE20Q36093331-FC3A5BB3-F41B-4F49-A96F-B31DE8063295Q36278242-A4D92AB8-2CC2-4F89-8F60-D1F330681D9BQ36426034-6FF02146-3DC0-4FAB-B441-F0A4FADA1EB4Q36533648-6587EE3F-9ED2-4493-A1B9-97C60600F27BQ36722761-F6560FE7-CE83-47A0-8F8B-9107DC16DCE4Q37284278-DF53DB6E-0D7A-4426-9683-BEF43FB7A5C6Q37629708-C95D426A-302D-4EFA-A757-46C9A0163594Q37704526-0C73F0D6-F8BB-4B47-B9EA-E901AAD6E6AFQ37827877-8AC8052F-32CE-49C0-86A7-348148222FA5Q38587559-2AB97343-59A5-4054-8E73-648703254C67Q38701265-B65557BC-A7AB-46C4-83FE-9119E0601ED0Q46043774-DC0C2A65-31D8-45A1-9933-A26EF76BF5CDQ51725862-72002C16-D4B2-406B-BD83-516F0D4DB56AQ54636548-AEE993A5-140D-49B2-8F83-495F4238A570Q55051715-680B1FDE-BAFE-498E-93B7-4243E7289207
P2860
Small intestinal bacterial overgrowth recurrence after antibiotic therapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Small intestinal bacterial overgrowth recurrence after antibiotic therapy.
@en
Small intestinal bacterial overgrowth recurrence after antibiotic therapy.
@nl
type
label
Small intestinal bacterial overgrowth recurrence after antibiotic therapy.
@en
Small intestinal bacterial overgrowth recurrence after antibiotic therapy.
@nl
prefLabel
Small intestinal bacterial overgrowth recurrence after antibiotic therapy.
@en
Small intestinal bacterial overgrowth recurrence after antibiotic therapy.
@nl
P2093
P2860
P1476
Small intestinal bacterial overgrowth recurrence after antibiotic therapy.
@en
P2093
Andrea Lupascu
Antonio Gasbarrini
Emidio Scarpellini
Ernesto C Lauritano
Giovanna Vitale
Giovanni Cammarota
Marialuisa Novi
Michele Serricchio
Sandra Sottili
Valentina Cesario
P2860
P304
P356
10.1111/J.1572-0241.2008.02030.X
P407
P577
2008-08-01T00:00:00Z